. Author manuscript; available in PMC: 2017 Jun 1.

Published in final edited form as: Lancet Respir Med. 2016 Oct 20;4(12):980–989. doi: 10.1016/S2213-2600(16)30319-8

Table 5.

Effect of immediate versus deferred antiretroviral therapy (ART) initiation on self-reported respiratory medication use

	Immediate ART		Deferred ART		p value^*
	n	Number (%) who reported respiratory medication use	n	Number (%) who reported respiratory medication use
Smokers

Year 1	117	3 (3%)	126	3 (2%)	1·00
Year 2	91	1 (1%)	99	4 (4%)	037
Year 3	54	1 (2%)	58	2 (3%)	1·00
Year 4	21	0	21	1 (5%)	1·00

Non-smokers

Year 1	339	8 (2%)	302	7 (2%)	1·00
Year 2	277	4 (1%)	242	4 (2%)	1·00
Year 3	120	3 (3%)	107	4 (4%)	071
Year 4	38	0	26	2 (8%)	0·16

Effects grouped by treatment and smoking status. Odds ratio from Generalised Estimating Equation with outcome as having used respiratory medications since the last study visit: for smokers 046 (95% CI 0·15–146), p=0·19; for non-smokers 056 (0·24–131), 0·18.

From Fisher’s exact test.